Clinical Trial Update: A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating BBI608 with pemetrexed and cisplatin in malignant pleural mesothelioma and non-small cell lung cancer has completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• BBI608
• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Sumitomo Pharma Co., Ltd. | Conditions: Malignant Pleural Mesothelioma, Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-01